Asahi Kasei Pharma, Vernalis Sign Joint Research Agreement for New Drug Discoveries for Autoimmune Diseases

October 3, 2013
Asahi Kasei Pharma announced on October 1 that it has entered into a joint research agreement with the UK-based Vernalis plc for new drug discoveries for autoimmune diseases including rheumatoid arthritis. The two companies aim to accelerate R&D in the...read more